Patent details

EP2255801 Title: Pharmaceutically active isoindoline derivatives

Basic Information

Publication number:
EP2255801
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101763902
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutically active isoindoline derivatives
French Title of Invention:
Dérivés d'isoindoline pharmaceutiquement actifs
German Title of Invention:
Pharmazeutisch aktive Isoindolin-Derivate
SPC Number:

Dates

Filing date:
09/11/2000
Grant date:
08/02/2012
EP Publication Date:
08/02/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/12/2010
EP B1 Publication Date:
08/02/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/11/2012
Expiration date:
09/11/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/11/2000
 
 

Name:
Celgene Corporation
Address:
86 Morris Avenue, Summit New Jersey 07901, United States (US)

Inventor

1

Name:
Muller George W.
Address:
United States (US)

2

Name:
Man Hon-Wah
Address:
United States (US)

Priority

1

Priority Number:
165168 P
Priority Date:
12/11/1999
Priority Country:
United States (US)

2

Priority Number:
590344
Priority Date:
08/06/2000
Priority Country:
United States (US)

3

Priority Number:
708199
Priority Date:
08/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4035;
Filing date Document type Number of pages